Login / Signup

Real-world effectiveness of IDegLira compared with intensified conventional insulin therapy in adults with type 2 diabetes: a retrospective cohort study.

Sándor SzépkútiSzilvia BandurGábor KovácsTamás FerenciMárk M SvébisPiroska TurbuczÁdám Gy Tabák
Published in: BMC endocrine disorders (2022)
Treatment with IDegLira over 18 months resulted in greater HbA1c reductions, weight loss versus gain, and a lower rate of hypoglycaemia versus ICT in people with type 2 diabetes.
Keyphrases
  • weight loss
  • type diabetes
  • randomized controlled trial
  • systematic review
  • bariatric surgery
  • glycemic control
  • roux en y gastric bypass
  • gastric bypass
  • combination therapy
  • body mass index
  • bone marrow